Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 23, pseudogene (RN7SL23P)

Target
RN7SL23P
Molecular classification
Pseudogene, Non-coding RNA pseudogene, Processed pseudogene
01

Overview

RNA, 7SL, cytoplasmic 23, pseudogene (RN7SL23P) is one of many pseudogenes derived from the retrotransposition of 7SL RNA, the RNA backbone of the signal recognition particle (SRP) complex, which is essential for targeting secretory and membrane proteins to the endoplasmic reticulum in eukaryotic cells[1][3][5][7]. Unlike the functional RN7SL1 gene (7SL RNA), pseudogenes such as RN7SL23P are truncated, often non-expressed genomic elements that do not encode an active RNA molecule and do not participate in SRP-mediated processes[3][6]. The RN7SL pseudogene family is large and diverse in structure; their main known biological significance is as passive genomic elements with possible rare roles as regulatory sequences, though RN7SL23P itself has not been implicated in any functional or disease processes[3][6]. Key points: - RN7SL23P is a non-functional pseudogene resulting from reverse transcription of the functional 7SL RNA gene[3][6]. - While some pseudogenes of other genes can have regulatory effects (e.g., as "sponges" for microRNAs), there is no evidence for such a role for this specific pseudogene[4][6]. - It is not a therapeutic target, does not encode a receptor, enzyme, or protein, and is not associated with drug interactions or disease biomarkers.

Other names
RN7SL23P7SL RNA pseudogene 23RNA, 7SL, cytoplasmic, pseudogene 23
02

Biological functions

Other (does not encode a functional product; derives from signal recognition particle 7SL RNA gene but is non-functional)
03

Disease associations

Other (pseudogenes generally do not have direct roles in disease, although some can function as competitive endogenous RNAs or have regulatory impacts, but no evidence found for RN7SL23P specifically)

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 23, pseudogene (RN7SL23P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 23, pseudogene (RN7SL23P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call